Five-Stage Medicine Capture Architecture

**In plain terms:** the engine's frame for the 1910-2026 Western medicine arc as a five-stage institutional-capture progression. **Stage 1 (1910 Flexner Report):** educational enclosure via Carnegie + Rockefeller capital eliminating non-allopathic schools. **Stage 2 (1986 NCVIA):** liability shield severing manufacturer-side risk from product-side profit, enabling 23→88 dose schedule expansion. **Stage 3 (1992 PDUFA):** regulatory capture via industry-funded FDA (~66% human-drugs-program budget by 2022) + revolving door + PhRMA $12.9M Q1 2025 lobby. **Stage 4 (2018 DEFUSE → 2020 Proximal Origin):** GoF dual-use research apparatus + Mind-War cover-up of the laboratory-origin hypothesis. **Stage 5 (2025-2026 RFK shatter):** institutional collapse + ACIP reconstitution + WHO exit + DOGE HHS purge + AHA reorientation. Each stage was structurally guaranteed by the prior stage; the architecture's collapse on the 138-year Phoenix Cycle horizon was BST-determined. **Forward watch (Report #84, May 7 2026):** the MV Hondius hantavirus outbreak tested the post-shatter IHR operational posture and the bilateral-substitution architecture (CDC monitored 5-state residents through direct intelligence sharing with European and African counterparts) was confirmed operational. Multipolar IHR architecture validated - US no longer load-bearing as keystone. Whether the new operational posture also resolves the broader drug-approval / pricing / regulatory capture layers remains under observation.